REVVITY, INC Share-based Payment Arrangement, Expense, Tax Benefit
REVVITY, INC (RVTY) reported Share-based Payment Arrangement, Expense, Tax Benefit of $5.30 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-02-24
- REVVITY, INC share-based payment arrangement, expense, tax benefit for the quarter ending 2021-10-03 was $4.10M, a 86.36% increase year-over-year.
- REVVITY, INC share-based payment arrangement, expense, tax benefit for the quarter ending 2021-07-04 was $4.10M, a 86.36% increase year-over-year.
- REVVITY, INC share-based payment arrangement, expense, tax benefit for the quarter ending 2021-04-04 was $4.10M, a 86.36% increase year-over-year.
- REVVITY, INC share-based payment arrangement, expense, tax benefit for the quarter ending 2021-01-03 was $6.20M, a 287.50% increase year-over-year.
- REVVITY, INC share-based payment arrangement, expense, tax benefit for fiscal 2025 was $5.30M, a 33.75% decline from fiscal 2024.
- REVVITY, INC share-based payment arrangement, expense, tax benefit for fiscal 2024 was $8.00M, a 24.53% decline from fiscal 2023.
- REVVITY, INC share-based payment arrangement, expense, tax benefit for fiscal 2023 was $10.60M, a 17.19% decline from fiscal 2023.
- REVVITY, INC share-based payment arrangement, expense, tax benefit for fiscal 2023 was $12.80M, a 4.92% increase from fiscal 2022.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 3 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-28 | $5.30M 10-K · filed 2026-02-24 | |||||
| 2024-12-29 | $8.00M 10-K · filed 2026-02-24 | |||||
| 2023-12-31 | $10.60M 10-K · filed 2026-02-24 | |||||
| 2023-01-01 | $12.80M 10-K · filed 2025-02-25 | |||||
| 2022-01-02 | $12.20M 10-K · filed 2024-02-27 | $14.00M 10-K · filed 2022-03-03 | ||||
| 2021-10-03 | $4.10M 10-Q · filed 2021-11-09 | $8.20M derived: sum of 2 quarters · filed 2021-11-09 | $12.30M derived: sum of 3 quarters · filed 2021-11-09 | $18.50M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-07-04 | $4.10M 10-Q · filed 2021-08-10 | $8.20M derived: sum of 2 quarters · filed 2021-08-10 | $14.40M derived: sum of 3 quarters · filed 2023-03-01 | $16.60M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-04-04 | $4.10M 10-Q · filed 2021-05-11 | $10.30M derived: sum of 2 quarters · filed 2023-03-01 | $12.50M derived: sum of 3 quarters · filed 2023-03-01 | $14.70M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-01-03 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.40M derived: sum of 2 quarters · filed 2023-03-01 | $10.60M derived: sum of 3 quarters · filed 2023-03-01 | $18.00M 10-K · filed 2023-03-01 | $17.20M 10-K · filed 2021-03-02 | |
| 2020-10-04 | $2.20M 10-Q · filed 2021-11-09 | $6.30M 10-Q · filed 2020-11-10 | $4.40M derived: sum of 2 quarters · filed 2021-11-09 | $11.80M 10-Q · filed 2020-11-10 | $8.20M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-07-05 | $2.20M 10-Q · filed 2021-08-10 | $3.30M 10-Q · filed 2020-08-11 | $5.50M 10-Q · filed 2020-08-11 | $6.00M derived: sum of 3 quarters · filed 2022-03-03 | $8.80M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-04-05 | $2.20M 10-Q · filed 2021-05-11 | $3.80M derived: sum of 2 quarters · filed 2022-03-03 | $6.60M derived: sum of 3 quarters · filed 2022-03-03 | $9.60M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2019-12-29 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $4.40M derived: sum of 2 quarters · filed 2022-03-03 | $7.40M derived: sum of 3 quarters · filed 2022-03-03 | $11.60M 10-K · filed 2022-03-03 | ||
| 2019-09-29 | $2.80M 10-Q · filed 2020-11-10 | $5.80M derived: sum of 2 quarters · filed 2020-11-10 | $10.00M 10-Q · filed 2020-11-10 | $13.00M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-06-30 | $3.00M 10-Q · filed 2020-08-11 | $7.20M 10-Q · filed 2020-08-11 | $10.20M derived: sum of 3 quarters · filed 2021-03-02 | $16.30M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-03-31 | $4.20M 10-Q · filed 2020-05-12 | $7.20M derived: sum of 2 quarters · filed 2021-03-02 | $13.30M derived: sum of 3 quarters · filed 2021-03-02 | $14.90M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2018-12-30 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $9.10M derived: sum of 2 quarters · filed 2021-03-02 | $10.70M derived: sum of 3 quarters · filed 2021-03-02 | $13.60M 10-K · filed 2021-03-02 | ||
| 2018-09-30 | $6.10M 10-Q · filed 2019-11-05 | $7.70M derived: sum of 2 quarters · filed 2019-11-05 | $10.60M 10-Q · filed 2019-11-05 | $15.40M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-07-01 | $1.60M 10-Q · filed 2019-08-06 | $4.50M 10-Q · filed 2019-08-06 | $9.30M derived: sum of 3 quarters · filed 2020-02-25 | $11.20M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-04-01 | $3.10M 10-Q · filed 2019-05-07 | $7.70M derived: sum of 2 quarters · filed 2020-02-25 | $9.60M derived: sum of 3 quarters · filed 2020-02-25 | $14.70M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.50M derived: sum of 2 quarters · filed 2020-02-25 | $11.60M derived: sum of 3 quarters · filed 2020-02-25 | $14.50M 10-K · filed 2020-02-25 | ||
| 2017-10-01 | $1.90M 10-Q · filed 2018-11-06 | $7.00M derived: sum of 2 quarters · filed 2018-11-06 | $9.90M 10-Q · filed 2018-11-06 | $11.20M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-07-02 | $5.10M 10-Q · filed 2018-08-07 | $8.00M 10-Q · filed 2018-08-07 | $9.30M derived: sum of 3 quarters · filed 2019-02-26 | $11.60M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-04-02 | $2.90M 10-Q · filed 2018-05-08 | $4.20M derived: sum of 2 quarters · filed 2019-02-26 | $6.50M derived: sum of 3 quarters · filed 2019-02-26 | $11.80M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-01-01 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.60M derived: sum of 2 quarters · filed 2019-02-26 | $8.90M derived: sum of 3 quarters · filed 2019-02-26 | $10.50M 10-K · filed 2019-02-26 | ||
| 2016-10-02 | $2.30M 10-Q · filed 2017-11-07 | $7.60M derived: sum of 2 quarters · filed 2017-11-07 | $9.20M 10-Q · filed 2017-11-07 | $11.20M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-07-03 | $5.30M 10-Q · filed 2017-08-08 | $7.30M 10-Q · filed 2017-08-08 | $8.90M derived: sum of 3 quarters · filed 2018-02-27 | $10.30M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-04-03 | $1.90M 10-Q · filed 2017-05-09 | $3.60M derived: sum of 2 quarters · filed 2018-02-27 | $5.00M derived: sum of 3 quarters · filed 2018-02-27 | $6.40M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-01-03 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.10M derived: sum of 2 quarters · filed 2018-02-27 | $4.50M derived: sum of 3 quarters · filed 2018-02-27 | $5.80M 10-K · filed 2018-02-27 | ||
| 2015-10-04 | $1.40M 10-Q · filed 2016-11-08 | $2.80M derived: sum of 2 quarters · filed 2016-11-08 | $4.10M 10-Q · filed 2016-11-08 | $5.30M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-28 | $1.40M 10-Q · filed 2016-08-09 | $2.70M 10-Q · filed 2016-08-09 | $3.90M derived: sum of 3 quarters · filed 2017-02-28 | $4.70M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-29 | $1.30M 10-Q · filed 2016-05-10 | $2.50M derived: sum of 2 quarters · filed 2017-02-28 | $3.30M derived: sum of 3 quarters · filed 2017-02-28 | $5.10M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-28 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $2.00M derived: sum of 2 quarters · filed 2017-02-28 | $3.80M derived: sum of 3 quarters · filed 2017-02-28 | $5.40M 10-K · filed 2017-02-28 | ||
| 2014-09-28 | $800.00K 10-Q · filed 2015-11-10 | $2.60M derived: sum of 2 quarters · filed 2015-11-10 | $4.20M 10-Q · filed 2015-11-10 | $5.00M derived: sum of 4 quarters · filed 2016-03-01 | ||
| 2014-06-29 | $1.80M 10-Q · filed 2015-08-04 | $3.50M 10-Q · filed 2015-08-04 | $4.20M derived: sum of 3 quarters · filed 2016-03-01 | $5.40M derived: sum of 4 quarters · filed 2016-03-01 | ||
| 2014-03-30 | $1.60M 10-Q · filed 2015-05-05 | $2.40M derived: sum of 2 quarters · filed 2016-03-01 | $3.60M derived: sum of 3 quarters · filed 2016-03-01 | $4.60M derived: sum of 4 quarters · filed 2016-03-01 | ||
| 2013-12-29 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $2.00M derived: sum of 2 quarters · filed 2016-03-01 | $3.00M derived: sum of 3 quarters · filed 2016-03-01 | $4.40M 10-K · filed 2016-03-01 | ||
| 2013-09-29 | $1.20M 10-Q · filed 2014-11-04 | $2.20M derived: sum of 2 quarters · filed 2014-11-04 | $3.60M 10-Q · filed 2014-11-04 | $5.40M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $1.00M 10-Q · filed 2014-08-05 | $2.40M 10-Q · filed 2014-08-05 | $4.20M derived: sum of 3 quarters · filed 2015-02-24 | $5.80M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $1.40M 10-Q · filed 2014-05-06 | $3.20M derived: sum of 2 quarters · filed 2015-02-24 | $4.80M derived: sum of 3 quarters · filed 2015-02-24 | $6.30M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-30 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $3.40M derived: sum of 2 quarters · filed 2015-02-24 | $4.90M derived: sum of 3 quarters · filed 2015-02-24 | $6.80M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $1.60M 10-Q · filed 2013-11-05 | $3.10M derived: sum of 2 quarters · filed 2013-11-05 | $5.00M 10-Q · filed 2013-11-05 | $7.10M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-07-01 | $1.50M 10-Q · filed 2013-08-06 | $3.40M 10-Q · filed 2013-08-06 | $5.50M derived: sum of 3 quarters · filed 2014-02-25 | $5.80M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-04-01 | $1.90M 10-Q · filed 2013-05-06 | $4.00M derived: sum of 2 quarters · filed 2014-02-25 | $4.30M derived: sum of 3 quarters · filed 2014-02-25 | $6.00M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-01-01 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $2.40M derived: sum of 2 quarters · filed 2014-02-25 | $4.10M derived: sum of 3 quarters · filed 2014-02-25 | $5.10M 10-K · filed 2014-02-25 | ||
| 2011-10-02 | $300.00K 10-Q · filed 2012-11-06 | $2.00M derived: sum of 2 quarters · filed 2012-11-06 | $3.00M 10-Q · filed 2012-11-06 | $3.80M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-07-03 | $1.70M 10-Q · filed 2012-08-07 | $2.70M 10-Q · filed 2012-08-07 | $3.50M derived: sum of 3 quarters · filed 2013-02-26 | $4.80M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-04-03 | $1.00M 10-Q · filed 2012-05-08 | $1.80M derived: sum of 2 quarters · filed 2013-02-26 | $3.10M derived: sum of 3 quarters · filed 2013-02-26 | $4.30M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-01-02 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $2.10M derived: sum of 2 quarters · filed 2013-02-26 | $3.30M derived: sum of 3 quarters · filed 2013-02-26 | $4.70M 10-K · filed 2013-02-26 | ||
| 2010-10-03 | $1.30M 10-Q · filed 2011-11-04 | $2.50M derived: sum of 2 quarters · filed 2011-11-04 | $3.90M 10-Q · filed 2011-11-04 | |||
| 2010-07-04 | $1.20M 10-Q · filed 2011-08-10 | $2.60M 10-Q · filed 2011-08-10 | ||||
| 2010-01-03 | $4.80M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |